Greg E. Parry

University of Utah, Salt Lake City, Utah, United States

Are you Greg E. Parry?

Claim your profile

Publications (2)10.64 Total impact

  • L.K. Pershing · G.E. Parry · L.D. Lambert ·
    [Show abstract] [Hide abstract]
    ABSTRACT: The permeation enhancing property of 5% oleic acid in ethanol on -estradiol was investigated in vitro and in vivo using symmetrical and asymmetrical side-by-side diffusion cells and the human skin sandwich flap, respectively. -Estradiol permeability in vitro and in vivo was similar in 75% ethanol (ETOH). Oleic acid (5%) did not alter -estradiol permeability in vivo but increased permeability sixfold in vitro in symmetrical diffusion cells. -Estradiol permeability in oleic acid was not different from that in ETOH, however, using asymmetrical diffusion cells. Stratum corneum-to-vehicle partition coefficients of -estradiol in the vehicles were similar, yet fourfold more steroid was detected in skin biopsies from the in vitro symmetrical diffusion cells. Thus, oleic acid increased -estradiol permeability in vitro only when skin was equilibrated with fatty acid. Attention to in vitro diffusion cell design and its relevance in vivo is critical to defining the mechanisms of enhanced solute permeation.
    Pharmaceutical Research 11/1993; 10(12). DOI:10.1023/A:1018974131236 · 3.42 Impact Factor
  • Source
    Greg E. Parry · Paul Dunn · Vinod P. Shah · Lynn K. Pershing ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical experience demonstrates that oral acyclovir (ACV) is superior to topical ACV in treating recurrent cutaneous herpes simplex virus type 1 (HSV-1) infections. Cutaneous HSV-1 infections are complex in their pathology, affecting the basal epidermis in skin as well as establishing a latency phase in sensory ganglia. In vitro and in vivo human skin model systems were used in the present study to quantitate ACV disposition and absorption in skin and blood following two routes of administration and to investigate whether bioavailability differences were the result of insufficient drug delivery. Physiochemical and physiologic parameters determined from these experiments were used to develop a mathematical model to predict ACV disposition and absorption in human subjects. Model predictions and in vivo data agree; topical administration of commercial 5% ACV ointment and cream result in a 48 times greater total epidermal ACV concentration than after oral administration. Mathematical modeling of the ACV concentration gradient through the epidermis revealed, however, that the drug concentration in the target site of HSV-1 infections, the basal epidermis, is 2-3 times less after topical administration than after oral administration. Thus, the observed lack of clinical efficacy with topical ACV therapy in the recurring HSV-1 infection likely reflects the insufficient delivery of the drug to the target site of the HSV-1 infection, the basal epidermis.
    Journal of Investigative Dermatology 07/1992; 98(6):856-63. DOI:10.1111/1523-1747.ep12456948 · 7.22 Impact Factor

Publication Stats

73 Citations
10.64 Total Impact Points


  • 1992-1993
    • University of Utah
      • Department of Dermatology
      Salt Lake City, Utah, United States